Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 1,773
CEO Mr. Herve Hoppenot
Address 1801 Augustine Cut-Off , Wilmington, DE 19803
Phone 1.302.498.6700
Website www.incyte.com

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Incyte Corp. -9.59% -12.54%
Pfizer Inc. 13.89% 27.38%
Novo Nordisk A/S 21.12% 43.52%
Danaher Corp. 26.13% 57.10%
Abbott Laboratories 13.18% 16.85%

Statement Summary

as of 4:00 ET PM 09/17/2021
Total Assets (MRQ) 3.9 B
Total Liabilities (MRQ) 968.8 M
Shareholders’ Equity (MRQ) 2.9 B
Total Revenue (Annual) 705.7 M
Net Income (Annual) 149.5 M

Earnings And Estimates

as of 4:00 ET PM 09/17/2021

Current Qtr EPS Estimate 0.56
Current FY EPS Estimate 2.10
Long Term EPS Growth Estimate 63.96
Next Expected Earnings Date //

INCY vs S&P 500

as of 09/17/2021
Relative To
S&P 500
INCY
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 09/17/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 0.55 0.67 +21.02%
03/2021 0.45 0.24 -46.86%
12/2020 0.54 0.68 +26.26%
09/2020 0.51 -0.07 -113.69%
06/2020 0.48 1.32 +173.86%
03/2020 0.35 -3.33 -1,058.27%
12/2019 0.36 0.51 +43.37%
09/2019 0.44 0.59 +33.03%

Financial Strength

as of 4:00 ET PM 09/17/2021
Pre-Tax Margin 24.32
Net Margin -49.81
Operating Margin 22.01
Return On Equity 12.79
Return On Assets 9.49
Inventory Turnover (TTM) 10.34
Sales Growth (MRQ) 28.75

Ratios

as of 4:00 PM ET 09/17/2021
Price/Earnings (TTM) 49.94
Price/Book (MRQ) 5.70
Price/Cash Flow (TTM) 25.24
Book Value (MRQ) 13.32
Quick Ratio (MRQ) 3.94
Current Ratio (MRQ) 3.97
Total Debt/Equity (MRQ) 0.02

Short Interest

as of 4:00 PM ET 09/20/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 09/17/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $0.56 $0.61
# of Estimates 10 11
High Estimate $0.71 $0.93
Low Estimate $0.47 $0.43
Year Ago EPS $-0.07 $0.68
Year Over Year Growth Estimate -910.07% -10.49%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $2.10 $3.52
# of Estimates 12 12
High Estimate $2.68 $4.51
Low Estimate $1.83 $2.04
Year Ago EPS $-1.36 $2.10
Year Over Year Growth Estimate -254.11% 68.07%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $0.56 $0.61 $2.10 $3.52
# of Estimates 10 11 12 12
High Estimate $0.71 $0.93 $2.68 $4.51
Low Estimate $0.47 $0.43 $1.83 $2.04
Year Ago EPS $-0.07 $0.68 $-1.36 $2.10
Year Over Year Growth Estimate -910.07% -10.49% -254.11% 68.07%

Insider Information Summary

as of 08/31/2021
% Insiders - 0.89%
% Remaining Total Shares - 99.11%
Current 1 Month
Net Insider Transaction -1.26 K 54.12 K
Shares Bought 117.34 K 172.73 K
Shares Sold 118.60 K 118.61 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Evergrande Group Lead

Cramer's Mad Money Recap: Evergrande, Debt, Delta

Jim Cramer says don't get sucked into buying the dips. He can't be bullish until everyone else turns bearish, and we're still a long way away from that.

JPMorgan Chase Lead

JPMorgan Says Stock Decline Represents Buying Opportunity

'Our fundamental thesis remains unchanged, and we see the sell-off as an opportunity to buy the dip,' said JPMorgan strategist Kolanovic.

Shell Tops FTSE 100 As Q4 Earnings Top Forecasts Despite Oil Market Volatility

Shell to Sell Permian Assets to ConocoPhillips for $9.5 Billion

Shell has signed an agreement to sell its Permian basin assets to ConocoPhillips for $9.5 billion cash.